NO960631L - Fenoksyfenyl-cyklopentyl-hydroksyurinstoffer - Google Patents

Fenoksyfenyl-cyklopentyl-hydroksyurinstoffer

Info

Publication number
NO960631L
NO960631L NO960631A NO960631A NO960631L NO 960631 L NO960631 L NO 960631L NO 960631 A NO960631 A NO 960631A NO 960631 A NO960631 A NO 960631A NO 960631 L NO960631 L NO 960631L
Authority
NO
Norway
Prior art keywords
pct
date
above compounds
cyclopentylpropionic
phenoxyphenyl
Prior art date
Application number
NO960631A
Other languages
English (en)
Other versions
NO305595B1 (no
NO960631D0 (no
Inventor
Akiyoshi Kawai
Rodney W Stevens
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO960631L publication Critical patent/NO960631L/no
Publication of NO960631D0 publication Critical patent/NO960631D0/no
Publication of NO305595B1 publication Critical patent/NO305595B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydrogenated Pyridines (AREA)
NO960631A 1993-08-19 1996-02-16 Fenoksyfenyl-cyklopentyl-hydroksyurinstoffer, farmas°ytisk preparat og anvendelse derav NO305595B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20545393 1993-08-19
PCT/JP1994/001349 WO1995005360A1 (en) 1993-08-19 1994-08-15 Phenoxyphenyl cyclopentenyl hydroxyureas

Publications (3)

Publication Number Publication Date
NO960631L true NO960631L (no) 1996-02-16
NO960631D0 NO960631D0 (no) 1996-02-16
NO305595B1 NO305595B1 (no) 1999-06-28

Family

ID=16507136

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960631A NO305595B1 (no) 1993-08-19 1996-02-16 Fenoksyfenyl-cyklopentyl-hydroksyurinstoffer, farmas°ytisk preparat og anvendelse derav

Country Status (27)

Country Link
US (1) US5792882A (no)
EP (1) EP0720598B1 (no)
JP (1) JP2794343B2 (no)
KR (1) KR0170623B1 (no)
CN (1) CN1077568C (no)
AT (1) ATE171939T1 (no)
AU (1) AU674776B2 (no)
BR (1) BR9407314A (no)
CA (1) CA2169066C (no)
CO (1) CO4230229A1 (no)
CZ (1) CZ288358B6 (no)
DE (1) DE69413831T2 (no)
DK (1) DK0720598T3 (no)
EC (1) ECSP941144A (no)
EG (1) EG20530A (no)
ES (1) ES2121218T3 (no)
FI (1) FI114466B (no)
IL (1) IL110628A (no)
MY (1) MY111140A (no)
NO (1) NO305595B1 (no)
NZ (1) NZ269849A (no)
PE (1) PE57194A1 (no)
PL (1) PL176223B1 (no)
RU (1) RU2125987C1 (no)
TW (2) TW448144B (no)
WO (1) WO1995005360A1 (no)
ZA (1) ZA946253B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU703756B2 (en) * 1994-06-27 1999-04-01 Millennium Pharmaceuticals, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
ATE184272T1 (de) * 1994-11-10 1999-09-15 Pfizer Aryloxycycloalkenyl- und aryloxyiminocycloalkenyl-hydroxyharnstoffe mit 5-lipoxygenase inhibierender wirkung
WO1996016054A1 (en) * 1994-11-18 1996-05-30 Pfizer Pharmaceuticals Inc. Cycloalkenyl-n-hydroxyureas
EP1745774A3 (en) 1997-08-11 2007-04-11 Pfizer Products Inc. Solid pharmaceutical dispersions with enhanced bioavailability
US6121323A (en) * 1997-12-03 2000-09-19 3M Innovative Properties Company Bishydroxyureas
EP1841729B1 (en) * 2004-12-02 2011-01-12 Amorepacific Corporation 2-cyclopenten-1-one oxime derivatives inhibiting production of tnf-alpha
WO2009072807A2 (en) * 2007-12-03 2009-06-11 Amorepacific Corporation Pharmaceutical composition for preventing or treating fat metabolism-related diseases containing 2-cyclopentene-1-one oxime derivatives
AR078033A1 (es) 2009-04-03 2011-10-12 Plexxikon Inc Una dispersion solida, que contiene al compuesto {3-[5-(4-(cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico, composiciones y formulaciones que comprenden a dicha dispersion solida; metodos para fabricar dicha dispersion solida, formas 1 y 2 de
US8512464B2 (en) * 2009-12-02 2013-08-20 3M Innovative Properties Company Functionalized zirconia nanoparticles and high index films made therefrom

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222168A (en) * 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
ATE96427T1 (de) * 1989-02-03 1993-11-15 Wellcome Found Entzuendungshemmende arylderivate.
US5120752A (en) * 1989-12-28 1992-06-09 Abbott Laboratories Cyclopropyl derivative lipoxygenase inhibitors
GB9025514D0 (en) * 1990-11-23 1991-01-09 Wellcome Found Anti-inflammatory compounds
JP3007138B2 (ja) * 1990-11-27 2000-02-07 ファイザー製薬株式会社 新規なヒドロキサム酸とn―ヒドロキシ尿素誘導体およびそれらの組成物
JPH06256285A (ja) * 1990-12-11 1994-09-13 Pfizer Pharmaceut Co Ltd ヒドロキサム酸誘導体およびその用途
JPH05163229A (ja) * 1991-12-13 1993-06-29 Pfizer Pharmaceut Co Ltd 新規なシクロプロピル誘導体
JPH05294921A (ja) * 1992-04-17 1993-11-09 Pfizer Pharmaceut Co Ltd 新規なフェニル置換シクロアルキル尿素誘導体および組成物

Also Published As

Publication number Publication date
BR9407314A (pt) 1996-04-16
AU7350994A (en) 1995-03-14
CZ288358B6 (en) 2001-05-16
PL176223B1 (pl) 1999-05-31
DK0720598T3 (da) 1999-06-21
CO4230229A1 (es) 1995-10-19
WO1995005360A1 (en) 1995-02-23
RU2125987C1 (ru) 1999-02-10
CN1129440A (zh) 1996-08-21
TW418089B (en) 2001-01-11
EP0720598A1 (en) 1996-07-10
KR0170623B1 (ko) 1999-03-30
CZ48396A3 (en) 1996-07-17
NZ269849A (en) 1997-10-24
FI943799A0 (fi) 1994-08-18
PL313037A1 (en) 1996-05-27
EP0720598B1 (en) 1998-10-07
CN1077568C (zh) 2002-01-09
FI943799A (fi) 1995-02-20
PE57194A1 (es) 1995-02-07
NO305595B1 (no) 1999-06-28
MY111140A (en) 1999-08-30
CA2169066A1 (en) 1995-02-23
JPH08511031A (ja) 1996-11-19
JP2794343B2 (ja) 1998-09-03
DE69413831D1 (de) 1998-11-12
CA2169066C (en) 1999-06-22
EG20530A (en) 1999-07-31
US5792882A (en) 1998-08-11
FI114466B (fi) 2004-10-29
ATE171939T1 (de) 1998-10-15
IL110628A0 (en) 1994-11-11
KR960703845A (ko) 1996-08-31
IL110628A (en) 1998-12-27
ES2121218T3 (es) 1998-11-16
DE69413831T2 (de) 1999-02-25
ZA946253B (en) 1996-02-19
ECSP941144A (es) 1995-02-27
TW448144B (en) 2001-08-01
NO960631D0 (no) 1996-02-16
AU674776B2 (en) 1997-01-09

Similar Documents

Publication Publication Date Title
ATE206123T1 (de) Phenylxanthin-derivate
FI943948A0 (fi) Heterosykliset hiilihappojohdannaiset
ES2063507T3 (es) 3-amino-2-aril-quinuclidinas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
NO305950B1 (no) 1-amidinofenyl-pyrrolidoner, piperidinoner, azetinoner som plateaggregeringshemmere og farmasoeytiske preparater inneholdende forbindelsene
ES2149777T3 (es) Derivados de triazol que tienen actividad antifungica.
DK0782567T3 (da) Isothiourinstofderivater og fremgangsmåder til deres fremstilling
NO960631L (no) Fenoksyfenyl-cyklopentyl-hydroksyurinstoffer
BR9507677A (pt) Composto composição farmacéutica processo para a profilaxia ou para o tratamento de condições associadas à inflamação à artrite ou à dor em um mamifero uso do composto processo para a preparação do composto e novo intermediário
FI943931A0 (fi) Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina
IL113706A (en) N-hydroxyurea alkyl phenyl oxazoles and thiazoles uses thereof as anti-inflammatory agents and pharmaceutical compositions containing them
DK0646110T3 (da) N-substituerede 3-azabicyclo(3.2.0) heptanderivater som neuroleptika
ATE167180T1 (de) Cycloalkylhydroxyharnstoffe und ihre verwendung als lipoxy-genase-inhibitoren
FI935867A0 (fi) Tetrahydrobensazepinderivat som inhibiterar lipoxigenas
NO305799B1 (no) Nye kinolinderivater, farmas°ytiske preparater inneholdende slike derivater, deres anvendelse samt mellomprodukter

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees